The comparable potency for inhibition of pSmad2 in primary cells and in human lung tissue suggests that the epithelial αvβ6 integrin is the main driver of TGFβ activation in human IPF tissue. The gene discussed is TGFB1; the disease is idiopathic interstitial pneumonia.